The radiopharmaceutical industry in China is witnessing rapid expansion, supported by favorable policies, a growing clinical trial ecosystem, and continuous regulatory improvements. While not without ...
GCP ClinPlus is proud to have acted as the CRO partner, offering end-to-end support for Platinum Life Biotechnology Co., Ltd.’s stem cell therapy amimestrocel injection (brand name: Rui Bo Sheng). Th...
We’re honored to share that GCP ClinPlus was recognized at the 10th Annual Forum of the New Drug Founders Conference in Shanghai as a “Best Enabling Service Organization.”This prestigious award, se...
Great news for international researchers! China's recent release of the Regulations on Clinical Research and Clinical Transformation Application of Biomedical New Technologies and the updated Drug...
After six days of layered analysis, we finally arrive at the concluding piece of the "GCP Insights · Seven-Day Series". The revisions in the GCP 2025 (Draft for Comment) represent not just ...
As clinical trials step into the digital age, data governance has become a core element in ensuring trial quality. By introducing a completely new [Data Governance] chapter, GCP 2025 establishes syste...
